Clinical Trial Update: Non-Invasive Assessment of Skeletal Muscle Loss in Cancer Patients - Phase II

View source ↗

Summary

Phase II study evaluating non-invasive methods to assess skeletal muscle loss in cancer patients with cachexia. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cachexia

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Cachexia | Status: COMPLETED